Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-16 · accession 0001415889-22-012797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-19 | 2022-12-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $1.50 | +8,424 | 21.2K | +66% | +$12.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | A | A | 8,424 | $1.50 | 21,157 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022. |